(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol

C31H52O3 — CID 152907352

IUPAC(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
SMILESC[C@H](CC[C@@](C)(O)C1CCOCC1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C31H52O3/c1-21(10-15-31(5,33)22-12-18-34-19-13-22)25-8-9-26-24-7-6-23-20-28(2,32)16-17-29(23,3)27(24)11-14-30(25,26)4/h6,21-22,24-27,32-33H,7-20H2,1-5H3/t21-,24+,25-,26+,27+,28+,29+,30-,31-/m1/s1
InChIKeyUGMXFIPKQRQGQG-XDAWFLGKSA-N
MW472.75 g/mol
LogP6.91
Rot. Bonds5

About (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol

(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol (PubChem CID 152907352) has the molecular formula C31H52O3 and a molecular weight of 472.75 g/mol. Its IUPAC name is (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol.

Molecular Properties

Compound Name(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
PubChem CID152907352
Molecular FormulaC31H52O3
Molecular Weight472.75 g/mol
Exact Mass472.39
IUPAC Name(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
SMILESC[C@H](CC[C@@](C)(O)C1CCOCC1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C31H52O3/c1-21(10-15-31(5,33)22-12-18-34-19-13-22)25-8-9-26-24-7-6-23-20-28(2,32)16-17-29(23,3)27(24)11-14-30(25,26)4/h6,21-22,24-27,32-33H,7-20H2,1-5H3/t21-,24+,25-,26+,27+,28+,29+,30-,31-/m1/s1
InChIKeyUGMXFIPKQRQGQG-XDAWFLGKSA-N
XLogP6.91
TPSA49.69 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500472.75
LogP ≤ 56.91
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol?
The IUPAC name of (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol (CID 152907352) is (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol.
What is the SMILES notation for (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol?
The canonical SMILES for (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol is C[C@H](CC[C@@](C)(O)C1CCOCC1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol?
The InChIKey is UGMXFIPKQRQGQG-XDAWFLGKSA-N. The full InChI is InChI=1S/C31H52O3/c1-21(10-15-31(5,33)22-12-18-34-19-13-22)25-8-9-26-24-7-6-23-20-28(2,32)16-17-29(23,3)27(24)11-14-30(25,26)4/h6,21-22,24-27,32-33H,7-20H2,1-5H3/t21-,24+,25-,26+,27+,28+,29+,30-,31-/m1/s1.
What are the key properties of (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol?
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol has a molecular weight of 472.75 g/mol, XLogP of 6.91, 5 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-5-(oxan-4-yl)hexan-2-yl]-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol is sourced from PubChem (CID 152907352), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).